#
Lymphomyosot
  • Professionals
  • FDA PI

Lymphomyosot

Dosage form: injection

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Lymphomyosot Description

Injection Solution Ingredient Information: Each 1.1ml ampule contains: Geranium robertianum 4X 1.1 mcl, Nasturtium aquaticum 4X 1.1 mcl, Ferrum iodatum 12X 1.1 mcl, Juglans regia 3X 0.55 mcl, Myosotis arvensis 3X 0.55 mcl, Scrophularia nodosa 3X 0.55 mcl, Teucrium scorodonia 3X 0.55 mcl, Veronica officinalis 3X 0.55 mcl, Equistetum hyemale 4X 0.55 mcl, Fumaria officinalis 4X 0.55 mcl, Natrum sulphuricum 4X 0.55 mcl, Pinus sylvestris 4X 0.55 mcl, Gentiana lutea 5X 0.55 mcl, Aranea diadema 6X 0.55 mcl, Sarsaparilla 6X 0.55 mcl, Calcarea phosphorica 12X 0.55 mcl, Levothyroxine 12X 0.55 mcl. Inactive Ingredients: Sterile Isotonic sodium chloride solution.

INDICATION AND USAGE

Lymphomyosot® Injection Solution is classified as a homeopathic combination drug.


Botanical Ingredients:
Equisetum hyemale (Horsetail), Fumaria officinalis (Common fumitory), Gentiana lutea (Yellow gentian), Geranium robertianum (Herb Robert), Juglans regia (Walnut), Myosotis arvensis (Forget-me-not), Nasturtium aquaticum (Watercress), Pinus sylvestris (Scotch Pine), Sarsaparilla (Wild liquorice), Scrophularia nodosa (Figwort), Teucrium scorodonia (Wood-germander), Veronica officinalis (Common speedwell).


Mineral Ingredients:
Calcarea phosphorica (Tribasic calcium phosphate), Ferrum iodatum (Ferrous iodide), Natrum sulphuricum (Disodium sulfate).


Animal-derived ingredients:
Aranea diadema (Papal-cross spider), Levothyroxine (L-thyroxine).


Lymphomyosot® Injection Solution is indicated for the temporary relief of swelling due to poor circulation, minor injury and environmental toxins.




Lymphomyosot Dosage and Administration

The dosage schedules listed can be used as a general guide for the administration of Lymphomyosot® Injection Solution. Lymphomyosot® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient's response therapy.


Adults and children 7 years and older: in acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3 times per week IM/SC/IV/ID. Children ages 2 to 6: receive 1/2 the adult dosage. Discard unused solution.


Lymphomyosot® Injection Solution may be administered intravenously, intramuscularly, subcutaneously, or intradermally. The required dose of Lymphomyosot® Injection Solution is first withdrawn from the ampule into the syringe, and the syringe is then shaken briefly. Lymphomyosot® Injection Solution should be administered using a narrow gauge needle (e.g. 22 to 30 gauge). Note: Parental drug products like Lymphomyosot® Injection Solution should be inspec